• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配方 pH 值和悬浮状态对铝佐剂冷冻诱导聚集的影响。

Influence of formulation pH and suspension state on freezing-induced agglomeration of aluminum adjuvants.

机构信息

Merck & Company, Inc., Merck Research Laboratories, West Point, Pennsylvania, USA.

出版信息

J Pharm Sci. 2012 Mar;101(3):1050-62. doi: 10.1002/jps.22815. Epub 2011 Nov 23.

DOI:10.1002/jps.22815
PMID:22113733
Abstract

Freezing and thawing of vaccines containing aluminum adjuvants can lead to formation of aggregates and loss in vaccine potency. We sought to understand whether and to what extent the freeze-thaw damage to aluminum adjuvants would differ based on suspension state (flocculation and settlement) at the time of freezing. As flocculation and settlement characteristics of aluminum adjuvants are driven largely by the electrostatic charges on the adjuvant particles, which, in turn, are strongly influenced by the pH of the suspension, we conducted freeze-thaw studies on both Adjuphos and Alhydrogel™ samples at three pH levels (4, 6.5, and 7.2) in buffer solutions with 9% sucrose. Significantly less aggregation occurred in the buffered sucrose solutions at the pH furthest from the aluminum adjuvant point of zero charge during slow freezing at -20°C. The freezing-induced aggregation for the samples with 9% sucrose at each pH was minimal during fast freezing at -70°C and -115°C. Suspensions that were flocculated and settled to a greater extent experienced the most freeze-thaw aggregation, whereas suspensions that were frozen before significant flocculation and settlement occurred showed little or no aggregation. Because pH of formulation can affect flocculation and settling time, it indirectly affects the extent of freeze-thaw aggregation.

摘要

含有铝佐剂的疫苗的冷冻和解冻会导致聚集物的形成和疫苗效力的丧失。我们试图了解在冷冻时的悬浮状态(絮凝和沉降)是否以及在何种程度上会导致铝佐剂的冷冻-解冻损伤不同。由于铝佐剂的絮凝和沉降特性主要取决于佐剂颗粒上的静电荷,而静电荷又强烈受到悬浮液 pH 的影响,因此我们在缓冲液中分别在三个 pH 值(4、6.5 和 7.2)和 9%蔗糖下对 Adjuphos 和 Alhydrogel™样品进行了冷冻-解冻研究。在缓慢冷冻至-20°C 时,远离铝佐剂零电荷点的 pH 值的缓冲蔗糖溶液中,聚集的情况明显较少。在-70°C 和-115°C 下快速冷冻时,每个 pH 值的 9%蔗糖样品的冷冻诱导聚集最小。经历更多冷冻-解冻聚集的絮凝和沉降程度较大的悬浮液,而在发生明显絮凝和沉降之前冷冻的悬浮液则几乎没有或没有聚集。由于配方的 pH 值会影响絮凝和沉降时间,因此它会间接影响冷冻-解冻聚集的程度。

相似文献

1
Influence of formulation pH and suspension state on freezing-induced agglomeration of aluminum adjuvants.配方 pH 值和悬浮状态对铝佐剂冷冻诱导聚集的影响。
J Pharm Sci. 2012 Mar;101(3):1050-62. doi: 10.1002/jps.22815. Epub 2011 Nov 23.
2
Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.单独使用氢氧化铝佐剂的冻融应激足以降低含有天然抗原的重组乙型肝炎疫苗的免疫原性。
Vaccine. 2014 Jun 24;32(30):3765-71. doi: 10.1016/j.vaccine.2014.05.037. Epub 2014 May 20.
3
Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.通过静态光散射和微流成像表征丙二醇减轻冷冻液体纳米外膜囊泡疫苗制剂的冻融团聚
PDA J Pharm Sci Technol. 2015 Jul-Aug;69(4):477-98. doi: 10.5731/pdajpst.2015.01057.
4
Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.冷冻干燥过程中氢氧化铝佐剂聚集的抑制作用。
J Pharm Sci. 2008 Jun;97(6):2049-61. doi: 10.1002/jps.21143.
5
Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.含铝盐佐剂疫苗的冻干稳定制剂的研发。
Vaccine. 2009 Jan 1;27(1):72-9. doi: 10.1016/j.vaccine.2008.10.027. Epub 2008 Oct 28.
6
Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.颗粒大小和抗原结合对模型溶菌酶疫苗中铝盐佐剂有效性的影响。
J Pharm Sci. 2008 Dec;97(12):5252-62. doi: 10.1002/jps.21390.
7
Investigation of the Sedimentation Behavior of Aluminum Phosphate: Influence of pH, Ionic Strength, and Model Antigens.磷酸铝沉降行为的研究:pH值、离子强度和模型抗原的影响
J Pharm Sci. 2015 Nov;104(11):3770-3781. doi: 10.1002/jps.24584. Epub 2015 Jul 23.
8
Physical and chemical changes in Alhydrogel™ damaged by freezing.冻融损伤的 AlhydrogelTM 的物理化学变化。
Vaccine. 2018 Nov 12;36(46):6902-6910. doi: 10.1016/j.vaccine.2018.10.023. Epub 2018 Oct 12.
9
NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants.氯化钠会显著改变氢氧化铝疫苗佐剂的物理化学性质。
Int J Pharm. 2017 Jan 30;517(1-2):226-233. doi: 10.1016/j.ijpharm.2016.12.019. Epub 2016 Dec 9.
10
Freeze-thaw stability of aluminum oxide nanoparticles.氧化铝纳米颗粒的冻融稳定性。
Int J Pharm. 2021 Sep 5;606:120932. doi: 10.1016/j.ijpharm.2021.120932. Epub 2021 Jul 24.

引用本文的文献

1
Self-assembling TLR2 agonists promote mucosal immune responses without pulmonary immunopathologic injuries in mice.自组装Toll样受体2(TLR2)激动剂可促进小鼠黏膜免疫反应,且不会造成肺部免疫病理损伤。
NPJ Vaccines. 2025 Jun 18;10(1):127. doi: 10.1038/s41541-025-01185-y.
2
Assessing Antigen-Adjuvant Complex Stability Against Physical Stresses By wNMR.通过 wNMR 评估抗原-佐剂复合物对抗物理应激的稳定性。
Pharm Res. 2023 Jun;40(6):1435-1446. doi: 10.1007/s11095-022-03437-1. Epub 2022 Nov 22.
3
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
探索模式识别受体激动剂作为候选佐剂。
Front Cell Infect Microbiol. 2021 Oct 6;11:745016. doi: 10.3389/fcimb.2021.745016. eCollection 2021.
4
Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.铝佐剂蛋白 D 缀合肺炎球菌疫苗在暴露于亚零下温度后的稳定性。
Hum Vaccin Immunother. 2018 May 4;14(5):1243-1250. doi: 10.1080/21645515.2017.1421878. Epub 2018 Feb 12.
5
Adjuvant formulations for virus-like particle (VLP) based vaccines.基于病毒样颗粒(VLP)疫苗的佐剂配方。
Clin Immunol. 2017 Oct;183:99-108. doi: 10.1016/j.clim.2017.08.004. Epub 2017 Aug 3.
6
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.用于大容量储存双突变体热不稳定毒素(dmLT)蛋白佐剂的候选稳定制剂的研发。
Vaccine. 2017 Oct 4;35(41):5471-5480. doi: 10.1016/j.vaccine.2017.03.101. Epub 2017 May 24.
7
Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components.含铝佐剂与b型流感嗜血杆菌及C群脑膜炎球菌结合疫苗及其组分的结合模式
Biologicals. 2015 Sep;43(5):355-62. doi: 10.1016/j.biologicals.2015.06.008. Epub 2015 Jul 17.
8
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.一种高度耐热的、含佐剂的人乳头瘤病毒疫苗的研发。
Eur J Pharm Biopharm. 2015 Aug;94:220-8. doi: 10.1016/j.ejpb.2015.05.009. Epub 2015 May 18.
9
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.含氢氧化铝和吡喃糖苷脂A佐剂的显性负抑制炭疽疫苗的玻璃态稳定化
J Pharm Sci. 2015 Feb;104(2):627-39. doi: 10.1002/jps.24295. Epub 2015 Jan 11.
10
Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.通过冷冻干燥稳定重组蓖麻毒素 A 亚单位疫苗。
Eur J Pharm Biopharm. 2013 Oct;85(2):279-86. doi: 10.1016/j.ejpb.2013.03.029. Epub 2013 Apr 10.